Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JBLU vs GSK✓SelectedUSD · GSKJBLU vs GSK performance historyLatest closeAs of-3.08%11/19
Stock and ETF performance explorer

JBLU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-76.0%
GSK return
+39.6%
Excess return
-115.5%
Maximum drawdown
-85.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-1.6%-1.5%-2.6%
7D-9.2%-4.7%-4.5%-7.9%
30D+18.9%-4.7%+23.6%+20.4%
3M-29.4%-8.8%-20.6%-27.6%
6M-21.0%-4.6%-16.4%-20.2%
YTD-24.0%+1.0%-24.9%-23.5%
1Y-15.6%+6.9%-22.5%-16.1%
3Y-17.4%+52.5%-70.0%-26.5%
5Y-76.0%+40.3%-116.3%-79.0%
All-76.0%+39.6%-115.5%-79.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling